Cargando…
Pharmacogenetic heterogeneity of transgene expression in muscle and tumours
BACKGROUND: Recombinant adenoviruses are employed to deliver a therapeutic transgene in the liver, muscle or tumour tissue. However, to rationalise this delivery approach, the factors of variation between individuals need to be identified. It is assumed that differences between inbred strains of lab...
Autores principales: | Lefesvre, Pierre, Attema, Joline, van Bekkum, Dirk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194725/ https://www.ncbi.nlm.nih.gov/pubmed/12943556 http://dx.doi.org/10.1186/1471-2210-3-11 |
Ejemplares similares
-
Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth
por: Lefesvre, Pierre, et al.
Publicado: (2002) -
Genetic heterogeneity in response to adenovirus gene therapy
por: Lefesvre, Pierre, et al.
Publicado: (2003) -
A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer
por: Lefesvre, Pierre, et al.
Publicado: (2002) -
Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005) -
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer
por: Sissung, Tristan M., et al.
Publicado: (2019)